AMpicillin-d5 manufacturers
- Ampicillin-D5
-
- $1528.00
-
2026-07-20
- CAS:1426173-65-0
- Purity: 97.49%
- Supply Ability: 10g
|
| | AMpicillin-d5 Basic information |
| Product Name: | AMpicillin-d5 | | Synonyms: | AMpicillin-d5;[2H5]-Ampicillin
(Mixture of Diastereomers);Micillin-D5;2H5]-Ampicillin;(2S,5R,6R)-6-[(2R)-2-amino-2-[(2,3,4,5,6-2H?)phenyl]acetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;D5-Ampicillin | | CAS: | 1426173-65-0 | | MF: | C16H14D5N3O4S | | MW: | 354.43556889 | | EINECS: | | | Product Categories: | | | Mol File: | 1426173-65-0.mol |  |
| | AMpicillin-d5 Chemical Properties |
| solubility | Water: Slightly Soluble | | form | A solid | | color | White to off-white | | Stability: | Hygroscopic |
| | AMpicillin-d5 Usage And Synthesis |
| Description | Ampicillin-d5 is intended for use as an internal standard for the quantification of ampicillin by GC- or LC-MS. Ampicillin is a broad-spectrum antibiotic with activity against Gram-positive and Gram-negative bacteria, including veterinary isolates of S. pseudintermedius, S. aureus, E. coli, Pasteurella, and S. canis (MIC50s = 0.25, 0.5, 2, 0.12, and 0.25 μg/ml, respectively).1 In vivo, ampicillin (80 mg/kg, i.v.) reduces cough frequency, tachypnea, dyspnea, and fever and increases survival in a baboon (P. cynocephalus) model of pneumococcal pneumonia.2 Formulations containing ampicillin have been used to treat a variety of bacterial infections. | | Uses | Labelled Ampicillin. Orally active, semi-synthetic antibiotic | | IC 50 | β-lactam | | References | 1. Awji, E.G., Damte, D., Lee, S.-J., et al. The in vitro activity of 15 antimicrobial agents against bacterial isolates from dogs J. Vet. Med. Sci. 74(8),1091-1094(2012).
2. Reyes, L.F., Restrepo, M.I., Hinojosa, C.A., et al. A non-human primate model of severe pneumococcal pneumonia PLoS One 11(11),e0166092(2016). |
| | AMpicillin-d5 Preparation Products And Raw materials |
|